Perspective Therapeutics, Inc. (CATX) vs RxSight, Inc. (RXST)
- Perspective Therapeutics, Inc. CATX 2.17 −7.26%
- RxSight, Inc. RXST 4.51 −3.43%
Perspective Therapeutics, Inc. and RxSight, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $267.1M against $194.2M — 1.4× the size. RxSight, Inc. grew revenue faster over the last twelve months: −13.3% against −66.9%. RxSight, Inc. has the higher net margin (−36.8% vs −28,468.0%) and the higher return on invested capital (−63.2% vs −88.4%). Across the 18 metrics below, RxSight, Inc. leads on 14 and Perspective Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | CATX | RXST | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | 77.50% | 56.01% |
| Operating margin | (30,619.07%) | (43.20%) | (15.03%) |
| Net margin | (28,467.97%) | (36.80%) | (20.40%) |
| Free cash flow margin | (29,630.07%) | (21.29%) | (7.24%) |
| Return on equity | (39.50%) | (17.35%) | (15.32%) |
| Return on assets | (33.14%) | (14.19%) | (19.72%) |
| Return on invested capital | (88.41%) | (63.16%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack